BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28789987)

  • 1. Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity.
    Neumann DP; Goodall GJ; Gregory PA
    Semin Cell Dev Biol; 2018 Mar; 75():50-60. PubMed ID: 28789987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT).
    Warzecha CC; Carstens RP
    Semin Cancer Biol; 2012 Oct; 22(5-6):417-27. PubMed ID: 22548723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
    Göttgens EL; Span PN; Zegers MM
    Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
    Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
    Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
    Vadlamudi Y; Dey DK; Kang SC
    Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition.
    Yang Y; Park JW; Bebee TW; Warzecha CC; Guo Y; Shang X; Xing Y; Carstens RP
    Mol Cell Biol; 2016 Jun; 36(11):1704-19. PubMed ID: 27044866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alternative splicing side of cancer.
    Biamonti G; Catillo M; Pignataro D; Montecucco A; Ghigna C
    Semin Cell Dev Biol; 2014 Aug; 32():30-6. PubMed ID: 24657195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Alternative Splicing during Epithelial-Mesenchymal Transition.
    Lyu J; Cheng C
    Cells Tissues Organs; 2022; 211(2):238-251. PubMed ID: 34348273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
    Qiu Y; Lyu J; Dunlap M; Harvey SE; Cheng C
    RNA; 2020 Sep; 26(9):1257-1267. PubMed ID: 32467311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).
    Biamonti G; Bonomi S; Gallo S; Ghigna C
    Cell Mol Life Sci; 2012 Aug; 69(15):2515-26. PubMed ID: 22349259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting the dots: chromatin and alternative splicing in EMT.
    Warns JA; Davie JR; Dhasarathy A
    Biochem Cell Biol; 2016 Feb; 94(1):12-25. PubMed ID: 26291837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.
    Harvey SE; Xu Y; Lin X; Gao XD; Qiu Y; Ahn J; Xiao X; Cheng C
    RNA; 2018 Oct; 24(10):1326-1338. PubMed ID: 30042172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA binding protein quaking regulates formation of circRNAs.
    Conn SJ; Pillman KA; Toubia J; Conn VM; Salmanidis M; Phillips CA; Roslan S; Schreiber AW; Gregory PA; Goodall GJ
    Cell; 2015 Mar; 160(6):1125-34. PubMed ID: 25768908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
    Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
    Elife; 2018 Jul; 7():. PubMed ID: 30059005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.
    Shapiro IM; Cheng AW; Flytzanis NC; Balsamo M; Condeelis JS; Oktay MH; Burge CB; Gertler FB
    PLoS Genet; 2011 Aug; 7(8):e1002218. PubMed ID: 21876675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-Mediated KHSRP Silencing Rewires Distinct Post-transcriptional Programs during TGF-β-Induced Epithelial-to-Mesenchymal Transition.
    Puppo M; Bucci G; Rossi M; Giovarelli M; Bordo D; Moshiri A; Gorlero F; Gherzi R; Briata P
    Cell Rep; 2016 Jul; 16(4):967-978. PubMed ID: 27396342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone marks regulate the epithelial-to-mesenchymal transition via alternative splicing.
    Segelle A; Núñez-Álvarez Y; Oldfield AJ; Webb KM; Voigt P; Luco RF
    Cell Rep; 2022 Feb; 38(7):110357. PubMed ID: 35172149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of RNA-binding protein and alternative splicing event associations during epithelial-mesenchymal transition based on inductive matrix completion.
    Qiu Y; Ching WK; Zou Q
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33517359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing.
    Hu X; Harvey SE; Zheng R; Lyu J; Grzeskowiak CL; Powell E; Piwnica-Worms H; Scott KL; Cheng C
    Nat Commun; 2020 Jan; 11(1):486. PubMed ID: 31980632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gene expression programmes by serine-arginine rich splicing factors.
    Änkö ML
    Semin Cell Dev Biol; 2014 Aug; 32():11-21. PubMed ID: 24657192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.